These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Development of a Biorelevant, Material-Sparing Membrane Flux Test for Rapid Screening of Bioavailability-Enhancing Drug Product Formulations. Stewart AM; Grass ME; Mudie DM; Morgen MM; Friesen DT; Vodak DT Mol Pharm; 2017 Jun; 14(6):2032-2046. PubMed ID: 28441497 [TBL] [Abstract][Full Text] [Related]
5. Utility of Films to Anticipate Effect of Drug Load and Polymer on Dissolution Performance from Tablets of Amorphous Itraconazole Spray-Dried Dispersions. Honick M; Sarpal K; Alayoubi A; Zidan A; Hoag SW; Hollenbeck RG; Munson EJ; Polli JE AAPS PharmSciTech; 2019 Nov; 20(8):331. PubMed ID: 31677012 [TBL] [Abstract][Full Text] [Related]
6. Characterization of Grades of HPMCAS Spray Dried Dispersions of Itraconazole Based on Supersaturation Kinetics and Molecular Interactions Impacting Formulation Performance. Adhikari A; Polli JE Pharm Res; 2020 Sep; 37(10):192. PubMed ID: 32914239 [TBL] [Abstract][Full Text] [Related]
7. Concordance of vacuum compression molding with spray drying in screening of amorphous solid dispersions of itraconazole. Dhumal G; Treffer D; Polli JE Int J Pharm; 2024 Apr; 654():123952. PubMed ID: 38417729 [TBL] [Abstract][Full Text] [Related]
8. Practical Approach to Modeling the Impact of Amorphous Drug Nanoparticles on the Oral Absorption of Poorly Soluble Drugs. Stewart AM; Grass ME Mol Pharm; 2020 Jan; 17(1):180-189. PubMed ID: 31743032 [TBL] [Abstract][Full Text] [Related]
9. Effects of Surfactants on Itraconazole-Hydroxypropyl Methylcellulose Acetate Succinate Solid Dispersion Prepared by Hot Melt Extrusion III: Tableting of Extrudates and Drug Release From Tablets. Solanki NG; Kathawala M; Serajuddin ATM J Pharm Sci; 2019 Dec; 108(12):3859-3869. PubMed ID: 31542437 [TBL] [Abstract][Full Text] [Related]
10. The effects of spray drying, HPMCAS grade, and compression speed on the compaction properties of itraconazole-HPMCAS spray dried dispersions. Honick M; Das S; Hoag SW; Muller FX; Alayoubi A; Feng X; Zidan A; Ashraf M; Polli JE Eur J Pharm Sci; 2020 Dec; 155():105556. PubMed ID: 32946956 [TBL] [Abstract][Full Text] [Related]
11. Bioavailability enhancement of itraconazole-based solid dispersions produced by hot melt extrusion in the framework of the Three Rs rule. Thiry J; Kok MG; Collard L; Frère A; Krier F; Fillet M; Evrard B Eur J Pharm Sci; 2017 Mar; 99():1-8. PubMed ID: 27951411 [TBL] [Abstract][Full Text] [Related]
12. Flocculated amorphous itraconazole nanoparticles for enhanced in vitro supersaturation and in vivo bioavailability. Miller MA; DiNunzio J; Matteucci ME; Ludher BS; Williams RO; Johnston KP Drug Dev Ind Pharm; 2012 May; 38(5):557-70. PubMed ID: 21961961 [TBL] [Abstract][Full Text] [Related]
13. Effects of Surfactants on Itraconazole-Hydroxypropyl Methylcellulose Acetate Succinate Solid Dispersion Prepared by Hot Melt Extrusion. II: Rheological Analysis and Extrudability Testing. Solanki NG; Gumaste SG; Shah AV; Serajuddin ATM J Pharm Sci; 2019 Sep; 108(9):3063-3073. PubMed ID: 31103788 [TBL] [Abstract][Full Text] [Related]
14. Hydroxypropyl methylcellulose acetate succinate as an exceptional polymer for amorphous solid dispersion formulations: A review from bench to clinic. Butreddy A Eur J Pharm Biopharm; 2022 Aug; 177():289-307. PubMed ID: 35872180 [TBL] [Abstract][Full Text] [Related]
15. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions. McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097 [TBL] [Abstract][Full Text] [Related]
16. Oral delivery of highly lipophilic poorly water-soluble drugs: spray-dried dispersions to improve oral absorption and enable high-dose toxicology studies of a P2Y1 antagonist. Chen XQ; Stefanski K; Shen H; Huang C; Caporuscio C; Yang W; Lam P; Su C; Gudmundsson O; Hageman M J Pharm Sci; 2014 Dec; 103(12):3924-3931. PubMed ID: 25308627 [TBL] [Abstract][Full Text] [Related]
17. The twofold advantage of the amorphous form as an oral drug delivery practice for lipophilic compounds: increased apparent solubility and drug flux through the intestinal membrane. Dahan A; Beig A; Ioffe-Dahan V; Agbaria R; Miller JM AAPS J; 2013 Apr; 15(2):347-53. PubMed ID: 23242514 [TBL] [Abstract][Full Text] [Related]
18. Effects of Surfactants on Itraconazole-HPMCAS Solid Dispersion Prepared by Hot-Melt Extrusion I: Miscibility and Drug Release. Solanki NG; Lam K; Tahsin M; Gumaste SG; Shah AV; Serajuddin ATM J Pharm Sci; 2019 Apr; 108(4):1453-1465. PubMed ID: 30395834 [TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of solid dispersions of itraconazole by using aerosol solvent extraction system for improvement in drug solubility and bioavailability. Lee S; Nam K; Kim MS; Jun SW; Park JS; Woo JS; Hwang SJ Arch Pharm Res; 2005 Jul; 28(7):866-74. PubMed ID: 16114503 [TBL] [Abstract][Full Text] [Related]
20. Nano-amorphous spray dried powder to improve oral bioavailability of itraconazole. Kumar S; Shen J; Burgess DJ J Control Release; 2014 Oct; 192():95-102. PubMed ID: 25009979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]